Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Opioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current

dc.contributor.authorFaber, Elizabeth (Louise)
dc.contributor.authorSah, Pankaj
dc.date.accessioned2015-12-13T22:51:00Z
dc.date.available2015-12-13T22:51:00Z
dc.date.issued2004
dc.date.updated2015-12-11T10:43:24Z
dc.description.abstractPyramidal neurons in the lateral amygdala discharge trains of action potentials that show marked spike frequency adaptation, which is primarily mediated by activation of a slow calcium-activated potassium current. We show here that these neurons also express an α-dendrotoxin- and tityustoxin-Kα-sensitive voltage-dependent potassium current that plays a key role in the control of spike discharge frequency. This current is selectively targeted to the primary apical dendrite of these neurons. Activation of μ-opioid receptors by application of morphine or D-Ala 2-N-Me-Phe4-Glycol5-enkephalin (DAMGO) potentiates spike frequency adaptation by enhancing the α -dendrotoxin-sensitive potassium current. The effects of μ-opioid agonists on spike frequency adaptation were blocked by inhibiting G-proteins with N-ethylmaleimide (NEM) and by blocking phospholipase A2. Application of arachidonic acid mimicked the actions of DAMGO or morphine. These results show that μ-opioid receptor activation enhances spike frequency adaptation in lateral amygdala neurons by modulating a voltage-dependent potassium channel containing Kv1.2 subunits, through activation of the phospholipase A 2-arachidonic acid-lipoxygenases cascade.
dc.identifier.issn0270-6474
dc.identifier.urihttp://hdl.handle.net/1885/81063
dc.publisherSociety for Neuroscience
dc.sourceJournal of Neuroscience
dc.subjectKeywords: arachidonic acid; calcium activated potassium channel; dendrotoxin; enkephalin[2 dextro alanine 4 methylphenylalanine 5 glycine]; guanine nucleotide binding protein; lipoxygenase; morphine; mu opiate receptor; mu opiate receptor agonist; n ethylmaleimide; Anxiolytic; Arachidonic; Channel; Kv1.2; Lipoxygenase; Nociception; Pain
dc.titleOpioids inhibit lateral amygdala pyramidal neurons by enhancing a dendritic potassium current
dc.typeJournal article
local.bibliographicCitation.issue12
local.bibliographicCitation.lastpage3039
local.bibliographicCitation.startpage3031
local.contributor.affiliationFaber, Elizabeth (Louise), College of Medicine, Biology and Environment, ANU
local.contributor.affiliationSah, Pankaj, College of Medicine, Biology and Environment, ANU
local.contributor.authoruidFaber, Elizabeth (Louise), u4022051
local.contributor.authoruidSah, Pankaj, u8403812
local.description.notesImported from ARIES
local.description.refereedYes
local.identifier.absfor110903 - Central Nervous System
local.identifier.ariespublicationMigratedxPub9392
local.identifier.citationvolume24
local.identifier.doi10.1523/JNEUROSCI.4496-03.2004
local.identifier.scopusID2-s2.0-1642505790
local.type.statusPublished Version

Downloads